🟢 99/100

This product looks safe

  • Vitamin B9: 16.7mg is 16.7× the Tolerable Upper Intake Level (1.0mg)
  • 43% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Vitamin B9: 16.7mg is 16.7× the Tolerable Upper Intake Level (1.0mg)

Label Data

8 Gram(s) Serving Size
14 Servings
Other Combinations Product Type
43% Evidence Coverage

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
Cholesterol
Total Carbohydrates
5 Gram(s) (2% DV)
Protein
Vitamin A
3635 mcg RAE (404% DV)
Vitamin C
1000 mg (1111% DV)
380 mcg (32% DV)
✅ Within RDA (0.3× RDA of 1.2 mg) 📚 76 studies (Tier A: 0, B: 33)
RDA 1.2mg This product: 0.38mg
430 mcg (33% DV)
✅ Within RDA (0.3× RDA of 1.3 mg) 📚 12 studies (Tier A: 0, B: 1)
RDA 1.3mg This product: 0.43mg
20 mg NE (125% DV)
✅ 1.4× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 20mg UL 35mg
10 mg (588% DV)
📊 7.7× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 10mg UL 100mg
16.7 mcg DFE (4% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 16.7× (UL: 1.0 mg) 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 16.7mg UL 1.0mg
30 mcg (1250% DV)
📊 12.5× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.03mg
3 mg (60% DV)
✅ Within RDA (0.6× RDA of 5 mg) 📚 1 studies — no high-quality reviews
RDA 5mg This product: 3mg
Calcium
50 mg (4% DV)
20 mg (5% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 20mg
30 mg (273% DV)
✅ 2.7× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 30mg UL 40mg
2 mg (87% DV)
✅ Within RDA (0.9× RDA of 2.3 mg) 📚 8 studies — no high-quality reviews
RDA 2.3mg This product: 2mg UL 11mg
100 mcg (286% DV)
✅ 2.9× RDA — within safe limits 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.1mg
Potassium
25 mg (1% DV)
📊 Market median: 200.0mg (198 products) 📚 6 studies — no high-quality reviews
This product: 1mg

Other Ingredients

Maltodextrin Natural Flavors Citric Acid Malic Acid Stevia Silica Beta-Carotene

Label Claims — Verification

Nutrient
All Other (98% of products) Structure/Function (87% of products) Nutrient (16% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

⚠️ Warnings & Precautions

Produced in a facility that uses milk, soy, peanut, tree nut, wheat, egg, fish and shellfish ingredients.

🧪 Formulation Notes

Buffered formula

1000 mg Vitamin C 16 nutrients & 7 B vitamins Antioxidants & electrolytes

Additional Information

New

Product Details

DSLD Entry Date 2020-08-23
Product Type Other Combinations
Form Powder
Brand Resistance C
DSLD ID 232167
Data Updated 2026-04-11

Research Evidence

21 Research Sources
52 Avg Quality Score
13 Rct
4 Meta Analysis
2 Systematic Review
2 Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences
View all evidence for Alpha Lipoic Acid →

Compare Similar Products

View all Alpha Lipoic Acid products →